BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30201421)

  • 1. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
    Brittain C; McCarthy A; Irizarry MC; McDermott D; Biglan K; Höglinger GU; Lorenzl S; Del Ser T; Boxer AL; ; ; ;
    Parkinsonism Relat Disord; 2019 Mar; 60():138-145. PubMed ID: 30201421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Jabbari E; Holland N; Chelban V; Jones PS; Lamb R; Rawlinson C; Guo T; Costantini AA; Tan MMX; Heslegrave AJ; Roncaroli F; Klein JC; Ansorge O; Allinson KSJ; Jaunmuktane Z; Holton JL; Revesz T; Warner TT; Lees AJ; Zetterberg H; Russell LL; Bocchetta M; Rohrer JD; Williams NM; Grosset DG; Burn DJ; Pavese N; Gerhard A; Kobylecki C; Leigh PN; Church A; Hu MTM; Woodside J; Houlden H; Rowe JB; Morris HR
    JAMA Neurol; 2020 Mar; 77(3):377-387. PubMed ID: 31860007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
    Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
    Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
    Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
    Front Neurol; 2020; 11():574. PubMed ID: 32754109
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.
    Williams DR; Holton JL; Strand C; Pittman A; de Silva R; Lees AJ; Revesz T
    Brain; 2007 Jun; 130(Pt 6):1566-76. PubMed ID: 17525140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive supranuclear palsy.
    Giagkou N; Höglinger GU; Stamelou M
    Int Rev Neurobiol; 2019; 149():49-86. PubMed ID: 31779824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognition in corticobasal syndrome and progressive supranuclear palsy: a review.
    Burrell JR; Hodges JR; Rowe JB
    Mov Disord; 2014 Apr; 29(5):684-93. PubMed ID: 24757116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome.
    Sakurai K; Imabayashi E; Tokumaru AM; Hasebe S; Murayama S; Morimoto S; Kanemaru K; Takao M; Shibamoto Y; Matsukawa N
    Neuroimage Clin; 2015; 7():605-10. PubMed ID: 26082887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study.
    Stang CD; Turcano P; Mielke MM; Josephs KA; Bower JH; Ahlskog JE; Boeve BF; Martin PR; Upadhyaya SG; Savica R
    J Parkinsons Dis; 2020; 10(1):179-184. PubMed ID: 31594251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
    Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
    Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total Patient Delay: A Comparison of Patient and Clinician/Health System Delays in the Diagnosis of Progressive Supranuclear Palsy and Corticobasal Syndrome.
    Swallow DMA; Murchie P; Counsell CE
    Mov Disord Clin Pract; 2024 May; 11(5):478-487. PubMed ID: 38369623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caregiver strain in progressive supranuclear palsy and corticobasal syndromes.
    Kellermair L; Fuchs A; Eggers C; Schwingenschuh P; Kögl M; Fellner F; Forstner T; Mangesius S; Guger M; Ransmayr G
    J Neural Transm (Vienna); 2021 Oct; 128(10):1611-1621. PubMed ID: 34296340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of brain atrophy in PSP and CBS over 6 months and 1 year.
    Dutt S; Binney RJ; Heuer HW; Luong P; Attygalle S; Bhatt P; Marx GA; Elofson J; Tartaglia MC; Litvan I; McGinnis SM; Dickerson BC; Kornak J; Waltzman D; Voltarelli L; Schuff N; Rabinovici GD; Kramer JH; Jack CR; Miller BL; Rosen HJ; Boxer AL;
    Neurology; 2016 Nov; 87(19):2016-2025. PubMed ID: 27742814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
    Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study.
    Zhang Y; Walter R; Ng P; Luong PN; Dutt S; Heuer H; Rojas-Rodriguez JC; Tsai R; Litvan I; Dickerson BC; Tartaglia MC; Rabinovici G; Miller BL; Rosen HJ; Schuff N; Boxer AL
    PLoS One; 2016; 11(6):e0157218. PubMed ID: 27310132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn).
    Saito Y; Kamagata K; Wijeratne PA; Andica C; Uchida W; Takabayashi K; Fujita S; Akashi T; Wada A; Shimoji K; Hori M; Masutani Y; Alexander DC; Aoki S
    Front Neurol; 2022; 13():814768. PubMed ID: 35280291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
    Ozsancak C; Auzou P; Dujardin K; Quinn N; Destée A
    J Neurol; 2004 Nov; 251(11):1317-23. PubMed ID: 15592726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.